within Pharmacolibrary.Drugs.S_SensoryOrgans.S01A_Antiinfectives.S01AE06_Gatifloxacin;

model Gatifloxacin
  extends Pharmacolibrary.Drugs.ATC.S.S01AE06;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>S01AE06</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Gatifloxacin is a fourth-generation fluoroquinolone antibiotic used primarily for the treatment of bacterial conjunctivitis (eye infections) and formerly for systemic infections. Due to concerns about dysglycemia, its systemic use is now withdrawn or heavily restricted in many countries, but ophthalmic formulations are still used.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers after oral and intravenous administration.</p><h4>References</h4><ol><li><p>Perry, CM, et al., &amp; Lamb, HM (1999). Gatifloxacin. <i>Drugs</i> 58(4) 683–698. DOI:<a href=&quot;https://doi.org/10.2165/00003495-199958040-00010&quot;>10.2165/00003495-199958040-00010</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/10551438/&quot;>https://pubmed.ncbi.nlm.nih.gov/10551438</a></p></li><li><p>Kikuchi, J, et al., &amp; Nishimura, M (2007). Pharmacokinetics of gatifloxacin after a single oral dose in healthy young adult subjects and adult patients with chronic bronchitis, with a comparison of drug concentrations obtained by bronchoscopic microsampling and bronchoalveolar lavage. <i>Clinical therapeutics</i> 29(1) 123–130. DOI:<a href=&quot;https://doi.org/10.1016/j.clinthera.2007.01.005&quot;>10.1016/j.clinthera.2007.01.005</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/17379052/&quot;>https://pubmed.ncbi.nlm.nih.gov/17379052</a></p></li><li><p>Grasela, DM, et al., &amp; LaCreta, FP (2000). Safety and pharmacokinetics of a single oral dose of gatifloxacin in patients with moderate to severe hepatic impairment. <i>Pharmacotherapy</i> 20(6 Pt 2) 87S–94S. DOI:<a href=&quot;https://doi.org/10.1592/phco.20.8.87s.35187&quot;>10.1592/phco.20.8.87s.35187</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/10850525/&quot;>https://pubmed.ncbi.nlm.nih.gov/10850525</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Gatifloxacin;
